Aarey Drugs (India) Executives
| AAREYDRUGS | 48.22 0.90 1.90% |
Aarey Drugs employs about 8 people. The company is managed by 8 executives with a total tenure of roughly 0 years, averaging almost 0.0 years of service per executive, having 1.0 employees per reported executive. Discussion of Aarey Drugs' management performance can provide insight into the enterprise performance.
| A Kathawala Insider Chief Accountant |
| Milind Churi Insider Head Production |
Aarey |
Aarey Drugs Management Team Effectiveness
At this time, Aarey Drugs' Total Assets are relatively stable compared to the past year. As of 02/07/2025, Non Current Assets Total is likely to grow to about 250 M, while Other Current Assets are likely to drop slightly above 137.5 M. Aarey Drugs' management efficiency ratios could be used to measure how well Aarey Drugs manages its routine affairs as well as how well it operates its assets and liabilities.As of 02/07/2025, Common Stock Shares Outstanding is likely to drop to about 18.9 M. In addition to that, Net Income Applicable To Common Shares is likely to drop to about 69.5 M
Aarey Drugs Workforce Comparison
Aarey Drugs Pharmaceuticals is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 12,737. Aarey Drugs adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 0.01 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.01 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.01. Aarey Drugs Pharmace Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Aarey Drugs Pharmace Price Series Summation is a cross summation of Aarey Drugs price series and its benchmark/peer.
Aarey Drugs Notable Stakeholders
An Aarey Drugs stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Aarey Drugs often face trade-offs trying to please all of them. Aarey Drugs' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Aarey Drugs' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Nimit Ghatalia | Executive Director | Profile | |
| A Kathawala | Chief Accountant | Profile | |
| Milind Churi | Head Production | Profile | |
| Mihir BE | Chairman MD | Profile | |
| J Gohil | Head Plant | Profile | |
| Preeti Rathi | Company Officer | Profile | |
| Mira Ghatalia | Chief Officer | Profile | |
| Maruti Ugade | Head Logistic | Profile |
About Aarey Drugs Management Performance
The success or failure of an entity such as Aarey Drugs Pharmace often depends on how effective the management is. Aarey Drugs management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Aarey management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Aarey management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Aarey Drugs is entity of India. It is traded as Stock on NSE exchange.
Aarey Drugs Workforce Analysis
Traditionally, organizations such as Aarey Drugs use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Aarey Drugs within its industry.Aarey Drugs Manpower Efficiency
Return on Aarey Drugs Manpower
| Revenue Per Employee | 494.5M | |
| Revenue Per Executive | 494.5M | |
| Net Income Per Employee | 5.9M | |
| Net Income Per Executive | 5.9M | |
| Working Capital Per Employee | 142.9M | |
| Working Capital Per Executive | 142.9M |
Additional Tools for Aarey Stock Analysis
When running Aarey Drugs' price analysis, check to measure Aarey Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarey Drugs is operating at the current time. Most of Aarey Drugs' value examination focuses on studying past and present price action to predict the probability of Aarey Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarey Drugs' price. Additionally, you may evaluate how the addition of Aarey Drugs to your portfolios can decrease your overall portfolio volatility.